Is hip replacement right for someone your age?

Being told you may need a hip replacement at 45 or 52 tends to provoke a single, immediate question: am I not too young for this? It is a reasonable concern — but age alone is not the deciding factor, and it rarely should be.

What actually determines whether hip replacement is appropriate is a combination of clinical findings: the pattern of your pain, how much function you have lost, what imaging shows about joint damage, and whether conservative treatments have run their course. A patient in their late forties with severely degenerated cartilage and persistent groin pain that limits daily life may be a clearer candidate than a 65-year-old with milder disease. The numbers on your birth certificate carry less weight than the state of your joint.

Professor Paul Lee, a Consultant Orthopaedic Surgeon with a published focus on hip replacement decision-making, describes the procedure as 'one of the most successful operations in medicine' when performed for the right indication with proper preparation — and notes that, under those conditions, a modern hip replacement can last over 30 years. That changes the calculation considerably for someone in their forties or fifties.

The three things worth understanding before anything else are when surgery becomes the right call, how long today's implants realistically last, and what daily life looks like afterwards. None of those questions can be answered by a checklist; they are resolved at a specialist consultation, where your specific symptoms, imaging, and goals are weighed together.

What moves the conversation toward replacement rather than waiting

Several clinical threads tend to converge when a specialist begins to weigh replacement seriously for a patient in their forties or fifties.

On examination, reduced internal rotation of the hip is one of the more telling physical signs — the joint's loss of that movement reflects structural change that is unlikely to be reversed by conservative measures. Deep groin pain, particularly pain that wakes a patient at night or limits walking distance to a few hundred metres, carries similar weight. Stair negotiation, the ability to put on shoes, and sleep quality are all functional markers that Professor Paul Lee considers alongside clinical findings and imaging: together they build a picture of how much the joint is already dictating the patient's life.

Imaging findings matter in proportion to symptoms. Significant joint space narrowing on X-ray, especially when it corresponds to the area generating pain, shifts the conversation — though imaging alone rarely makes the decision.

Conservative options such as viscosupplementation (gel injections) and micro-fragmented fat injections can be appropriate for patients with partial joint involvement and may delay the need for surgery. They do not repair structural damage, and it is worth understanding that distinction clearly: they manage symptoms in a joint that continues to degenerate. For some patients, that managed period is genuinely useful. For others, prolonged delay allows soft-tissue deterioration that may complicate both surgery and recovery.

Waiting is not automatically the more cautious path. The decision about when to proceed — and whether the clinical picture justifies replacement now or further joint-preserving strategies first — is made through specialist assessment, not by scoring symptoms at home. That assessment brings together examination findings, imaging, prior treatment history, and the patient's own functional goals.

How long a modern hip implant realistically lasts

Current data offers genuine reassurance here. Over 90% of modern hip replacements are still functioning well at 15 to 20 years — a figure that reflects the cumulative effect of three distinct advances: cementless fixation, improved bearing surfaces, and refined surgical technique. For a patient in their forties who will carry an implant for several decades, these are not abstract engineering details; they are the reason the longevity conversation has changed substantially in the last fifteen years.

Population-level registry data suggests approximately 58% of hip replacements survive to 25 years. That estimate is useful context, but it draws on a broad pool that includes older implant generations and patients with lower activity demands — so it should be read as a floor rather than a ceiling for what modern technology may achieve.

Fixation method matters particularly for younger patients. Cementless acetabular components are anchored by osseointegration — the living bone grows directly into the porous titanium surface of the cup, creating biological fixation that does not rely on a cement mantle that may eventually loosen. For an implant that may realistically need to last 30 or more years, that distinction is clinically significant. Bearing surfaces follow the same logic: highly cross-linked polyethylene and ceramic bearings generate substantially less wear debris than the metal-on-metal or conventional polyethylene pairings used in earlier decades, reducing the inflammatory response that can threaten long-term fixation.

Professor Paul Lee has published on long-term outcomes of cementless acetabular systems, and that research informs his implant selection approach for working-age patients. Under optimal conditions — the right implant, the right technique, and appropriate patient preparation — a 30-year functional lifespan is a realistic target. No implant carries a guarantee, and individual anatomy, activity level, and body weight all influence the outcome; but for a well-selected patient managed along a carefully designed pathway, the durability picture is considerably better than it was a generation ago.

The revision question: what younger patients need to understand

Revision surgery is a realistic possibility for patients who have hip replacement in their forties or fifties — not because modern implants wear out quickly, but because a 50-year-old may carry a prosthesis for 35 or 40 years. Over that horizon, even a well-performing implant accumulates wear, and the likelihood of eventually needing a second procedure rises with years lived rather than with any early failure in the hardware itself.

Higher activity levels in working-age patients add to that picture. Remaining in employment, staying recreationally active, and carrying the physical demands of ordinary life all represent cumulative load on the bearing surfaces — which is precisely why material selection and fixation method carry more clinical weight for a 50-year-old than for a 75-year-old.

Population registries do not currently isolate revision rates for the 40–55 age bracket; the closest available figure is the approximate 58% 25-year survivorship noted in the previous section. That limitation means the question of how long before a revision might be needed cannot be answered with a specific number for this cohort. What it does reinforce is that the first operation's technical choices are the primary lever available for pushing that horizon out as far as possible.

Revision hip surgery is considerably more complex than a primary procedure: the anatomy is altered, bone stock may be reduced, and recovery tends to be longer. Professor Lee's approach to implant selection for younger patients — prioritising cementless osseointegration and durable bearing surfaces — is designed with exactly this long-term calculus in mind. Maximising the interval before any revision becomes necessary starts at the planning stage of the first operation, not later.

Why the SPAIRE approach matters for active patients in this age group

One of the clearest threads connecting surgical technique to long-term outcome is dislocation risk — and it bears directly on the revision question raised above.

In traditional posterior hip replacement, the surgeon divides the short external rotator tendons at the back of the hip to gain access to the joint. Those tendons — principally the piriformis and obturator internus — are the primary soft-tissue stabilisers of the posterior hip. Cutting them leaves a window of vulnerability during the early healing period, and younger age (under 65) is a recognised independent risk factor for dislocation in this setting. This is not an incidental statistic: approximately 45.6% of patients who experience a post-operative dislocation go on to require revision surgery within two years. Dislocation, in other words, is one of the more direct routes from a successful primary procedure to the revision operating table.

The SPAIRE technique — developed at the Exeter Hip Unit, where Professor Lee trained under Professor Timperley — is designed to address this by preserving those posterior tendons entirely rather than dividing and reattaching them. The acronym reflects the intent: Saves Piriformis And (Obturator) Internus with Repair of (Obturator) Externus. Leaving the stabilising structures intact may support earlier confidence in movement and is designed to reduce the instability risk that is particularly relevant for working-age patients planning to return to an active life. For someone in their forties or fifties — typically still working, still recreationally active — that biological advantage in early recovery has practical consequence.

SPAIRE is not the appropriate choice for every patient. Suitability depends on anatomy, body habitus, and the operating surgeon's assessment at planning stage. In selected patients for whom the approach is indicated, however, the rationale is grounded in a straightforward clinical logic: preserving the structures that stabilise the joint reduces the risk of the complication most likely to force an early return to theatre.

What life after hip replacement looks like at working age

Recovery, for most patients who reach a good outcome, eventually stops feeling like recovery at all. The goal Professor Lee describes is a 'forgotten joint' — a replaced hip that no longer dominates daily awareness, shapes decisions about activity, or intrudes on work and ordinary life. That outcome is a credible aspiration for patients in their forties and fifties, not a guarantee, and the honest framing matters.

Within this pathway, suitable patients may be discharged on the same day or the following morning — a pathway Professor Lee designed specifically to integrate technique, implant selection, mobilisation, and recovery planning as a single journey rather than a sequence of disconnected steps. Individual anatomy and recovery always determine what is actually possible, and same-day discharge is not the right outcome for everyone.

Activity expectations after a well-executed replacement are generally good. Walking, swimming, and cycling are achievable for most; what is appropriate for higher-impact pursuits depends on implant type, fixation, and how recovery has progressed — a conversation between patient and surgeon, not a universal rule. Precise restrictions for more demanding activities are always assessed individually.

Patients who reach the forgotten-joint outcome tend to describe the prosthetic hip as indistinguishable from a healthy one in everyday life. If the picture described across this article — progressive pain, lost movement, exhausted conservative options — reflects your own situation, a specialist assessment is the natural next step toward understanding whether that outcome is within reach.

1. [1] Joint replacement – Wikipedia. https://en.wikipedia.org/?curid=2867638 https://en.wikipedia.org/?curid=2867638
2. [2] Hip replacement – NHS. https://www.nhs.uk/conditions/hip-replacement/ https://www.nhs.uk/conditions/hip-replacement/
3. [3] Hip replacement – Wikipedia. https://en.wikipedia.org/?curid=1125423 https://en.wikipedia.org/?curid=1125423